Science & Technology
Evaluating Hbvz10-Based Therapied for Cccdna Clearance: Virological Foundation and Synergistic Combinations
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N93025C00023
Award Ceiling
$606K
Award Floor
$606K
Close Date
N/A
Total Funding
$606K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N93025C00023
Description
SBIR Phase Phase I award: "EVALUATING HBVZ10-BASED THERAPIED FOR CCCDNA CLEARANCE: VIROLOGICAL FOUNDATION AND SYNERGISTIC COMBINATIONS" awarded to HBVtech in Germantown, Maryland. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $606,178. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.